Metastatic cancer-related thrombotic microangiopathies: a cohort study. - Wikidata - awgldk - TriplyDB

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

http://www.wikidata.org/entity/Q33418105

about

Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience.Thrombotic Microangiopathy Revealing Bone Metastases from an Ethmoid Sinus Carcinoma.

P2860

Q36709018-B846C549-89CF-40BD-A059-44DE3C192EF6 Q41238573-92A7103A-A0AD-492D-BCFC-10D9223EBE97

P2860

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

http://www.wikidata.org/entity/Q33418105

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@ast

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@en

type

label

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@ast

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@en

prefLabel

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@ast

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@en

P1433

Q33418105-CAF49406-C974-49B0-9B91-B86F70AFA43A

P1476

Q33418105-161C868B-814D-4426-A34D-DB533B594780

P2093

Q33418105-2B4468D3-ABD8-4DAD-85EB-D0C3213E7CF0

Q33418105-3AAE127B-9559-4FD7-85CE-05873CD962FE

Q33418105-52AA4669-0108-4D51-9977-D6694157B0AB

Q33418105-851D2C90-DA66-4ABC-A7DA-5EF3E28354DD

Q33418105-AA6D23B4-B1B3-4E88-8DAB-09C851285352

Q33418105-B214A890-95AA-4657-A4E1-5C1CA9E1456E

Q33418105-CC65E7E8-7891-424F-B369-D16BEC844A21

Q33418105-DFAA9B6C-2B57-4AAE-96FB-DB46C27A2B46

Q33418105-FE025BDC-8369-4DA9-A74B-170CE82C4551

P2860

Q33418105-181335E1-4153-4CA4-BCF4-C7A375BA8DAC

Q33418105-1F3989AE-F646-4B16-8C08-2C8B69631C9E

Q33418105-26A49E3D-192F-4A8A-8063-6AFDC8B3CD97

Q33418105-55BC09F8-5488-4920-8757-62F12D5707F9

Q33418105-59CB289D-B1A2-4673-B95D-191990458ADE

Q33418105-769FBEE7-9604-4C4D-835A-E53B673094C8

Q33418105-77D1DBE9-C0FE-4F50-B3D3-E004DA6335FD

Q33418105-9877C687-C67E-4DBA-8A3D-E13D3B4CBC5C

Q33418105-A61825F5-9369-46E2-B873-05B338FCE543

Q33418105-CE37A262-9137-4F9E-A74B-4085BCC384EF

P304

Q33418105-8A0B86AE-09E5-482C-A478-E97C152EDB1D

P31

Q33418105-90395BCA-F1C8-4AF2-A8AF-203B33AB6F7E

P356

Q33418105-4BEBE11C-DD22-475B-9F6F-FEBC370649C1

P407

Q33418105-CD8DF563-BB63-4E59-85F9-BB5F22B3413F

P433

Q33418105-F3E3D124-69BA-4523-B51B-D3384C8D36C6

P478

Q33418105-B5689C18-41C5-4128-8FAA-BDF89DD7EA26

P50

Q33418105-E776694F-3001-4A80-8B16-F1161DB44647

Q33418105-F7AC3FE6-3987-4538-B54D-B8AF2DBF03FE

P577

Q33418105-544155C8-F896-4FFB-9119-2D0510C2DA9D

P5875

Q33418105-F0E1FD85-2A39-49A8-BD64-2277F12BEB11

P698

Q33418105-41D6C115-AAAC-40F1-8265-0E5C9F949C28

P356

P1433

Future Oncology

P1476

Metastatic cancer-related thrombotic microangiopathies: a cohort study.

@en

P2093

Agnes Veyradier

http://www.w3.org/2001/XMLSchema#string

Benoit Schlemmer

http://www.w3.org/2001/XMLSchema#string

Elie Azoulay

http://www.w3.org/2001/XMLSchema#string

Emmanuel Canet

http://www.w3.org/2001/XMLSchema#string

Eric Mariotte

http://www.w3.org/2001/XMLSchema#string

Guillaume Ducos

http://www.w3.org/2001/XMLSchema#string

Lara Zafrani

http://www.w3.org/2001/XMLSchema#string

Lionel Galicier

http://www.w3.org/2001/XMLSchema#string

Virginie Lemiale

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.

Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast.

Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer.

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange.

Management of cancer-associated thrombotic microangiopathy: what is the right approach?

Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases.

Cancer awareness in atypical thrombotic microangiopathies.

Thrombotic thrombocytopenic purpura: recognition and management.

Thrombotic microangiopathy and disseminated intravascular coagulation associated with carcinocythemia in a patient with breast cancer.

P304

1727-1734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.14.113

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266746205

http://www.w3.org/2001/XMLSchema#string

P698

25303053

http://www.w3.org/2001/XMLSchema#string